- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/06 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
Patent holdings for IPC class C07D 243/06
Total number of patents in this class: 34
10-year publication summary
|
2
|
0
|
4
|
3
|
2
|
2
|
0
|
1
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 228 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Cornell University | 3434 |
2 |
| Eagle Pharmaceuticals, Inc. | 102 |
2 |
| Lifearc | 48 |
2 |
| Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 22 |
2 |
| Bristol-myers Squibb Company | 4747 |
1 |
| F. Hoffmann-La Roche AG | 7816 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2666 |
1 |
| Glenmark Pharmaceuticals Limited | 109 |
1 |
| Katholieke Universiteit Leuven | 1292 |
1 |
| Katholieke Universiteit Leuven K.u. Leuven R & D | 203 |
1 |
| Massachusetts Eye and Ear Infirmary | 403 |
1 |
| Medshine Discovery Inc. | 588 |
1 |
| Memorial Sloan-Kettering Cancer Center | 2048 |
1 |
| Mimetica Pty Ltd | 6 |
1 |
| PAION UK Limited | 44 |
1 |
| Rigel Pharmaceuticals, Inc. | 505 |
1 |
| The Schepens Eye Research Institute, Inc. | 213 |
1 |
| Sloan-Kettering Institute for Cancer Research | 625 |
1 |
| Other owners | 6 |